###begin article-title 0
###xml 93 99 93 99 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL-1RN</italic>
Variable number of tandem repeat polymorphisms of the interleukin-1 receptor antagonist gene IL-1RN: a novel association with the athlete status
###end article-title 0
###begin title 1
Background
###end title 1
###begin p 2
The interleukin-1 (IL-1) family of cytokines is involved in the inflammatory and repair reactions of skeletal muscle during and after exercise. Specifically, plasma levels of the IL-1 receptor antagonist (IL-1ra) increase dramatically after intense exercise, and accumulating evidence points to an effect of genetic polymorphisms on athletic phenotypes. Therefore, the IL-1 family cytokine genes are plausible candidate genes for athleticism. We explored whether IL-1 polymorphisms are associated with athlete status in European subjects.
###end p 2
###begin title 3
Methods
###end title 3
###begin p 4
###xml 186 191 183 188 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL-1B</italic>
###xml 298 304 295 301 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL-1RN</italic>
Genomic DNA was obtained from 205 (53 professional and 152 competitive non-professional) Italian athletes and 458 non-athlete controls. Two diallelic polymorphisms in the IL-1beta gene (IL-1B) at -511 and +3954 positions, and a variable number tandem repeats (VNTR) in intron 2 of the IL-1ra gene (IL-1RN) were assessed.
###end p 4
###begin title 5
Results
###end title 5
###begin p 6
###xml 42 49 42 49 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL-1RN </italic>
###xml 266 273 266 273 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL-1RN </italic>
###xml 410 416 410 416 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL-1B </italic>
###xml 589 596 589 596 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL-1RN </italic>
We found a 2-fold higher frequency of the IL-1RN 1/2 genotype in athletes compared to non-athlete controls (OR = 1.93, 95% CI = 1.37-2.74, 41.0% vs. 26.4%), and a lower frequency of the 1/1 genotype (OR = 0.55, 95% CI = 0.40-0.77, 43.9% vs. 58.5%). Frequency of the IL-1RN 2/2 genotype did not differ between groups. No significant differences between athletes and controls were found for either -511 or +3954 IL-1B polymorphisms. However, the haplotype (-511)C-(+3954)T-(VNTR)2 was 3-fold more frequent in athletes than in non-athletes (OR = 3.02, 95% CI = 1.16-7.87). Interestingly, the IL-1RN 1/2 genotype was more frequent in professional than in non-professional athletes (OR = 1.92, 95% CI = 1.02-3.61, 52.8% vs. 36.8%).
###end p 6
###begin title 7
Conclusions
###end title 7
###begin p 8
###xml 176 183 176 183 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL-1RN </italic>
###xml 346 353 346 353 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL-1RN </italic>
###xml 142 147 <span type="species:ncbi:9606">human</span>
Our study found that variants at the IL-1ra gene associate with athletic status. This confirms the crucial role that cytokine IL-1ra plays in human physical exercise. The VNTR IL-1RN polymorphism may have implications for muscle health, performance, and/or recovery capacities. Further studies are needed to assess these specific issues. As VNTR IL-1RN polymorphism is implicated in several disease conditions, athlete status may constitute a confounding variable that will need to be accounted for when examining associations of this polymorphism with disease risk.
###end p 8
###begin title 9
Background
###end title 9
###begin p 10
###xml 297 298 297 298 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B1">1</xref>
###xml 560 561 560 561 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B1">1</xref>
###xml 562 563 562 563 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B5">5</xref>
###xml 709 710 702 703 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B6">6</xref>
###xml 1084 1085 1070 1071 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B7">7</xref>
###xml 1581 1582 1553 1554 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B6">6</xref>
###xml 1806 1807 1772 1773 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B1">1</xref>
###xml 1808 1809 1774 1775 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B2">2</xref>
###xml 2098 2099 2058 2059 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B8">8</xref>
###xml 2141 2142 2101 2102 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B9">9</xref>
###xml 2448 2449 2405 2406 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B8">8</xref>
###xml 2601 2602 2558 2559 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B4">4</xref>
###xml 2853 2855 2810 2812 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B10">10</xref>
###xml 2856 2858 2813 2815 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B11">11</xref>
###xml 983 989 <span type="species:ncbi:9606">humans</span>
###xml 1058 1065 <span type="species:ncbi:9606">infants</span>
###xml 2772 2778 <span type="species:ncbi:9606">people</span>
Factors that affect athletic performance are only partially defined. However, there are accumulating data indicating that both pro- and anti-inflammatory responses can play a role. Prolonged strenuous exercise results in an activation of the acute phase response with some similarities to sepsis [1]. The induction of a systemic cytokine response, including elevated plasma levels of interleukin (IL)-1 receptor antagonist (IL-1ra), IL-6, IL-8, IL-10, and granulocyte colony-stimulating factor (G-CSF), following intense physical activity, is well documented [1-5]. IL-1ra is a member of the IL-1 family, which includes the classical IL-1 (alpha and beta) cytokines, IL-18 and the newly described IL-1F 5-11 [6]. IL-1ra acts as an antagonist of the IL-1 receptor type I (IL-1RI) and prevents IL-1 (alpha and beta)-dependent signaling. In the absence of IL-1ra, the activity of IL-1 is unopposed, promoting rampant inflammation. Recent research has shown that deficiency of IL-1ra in humans can cause IL-1-mediated systemic and local inflammation that affect infants soon after birth [7]. IL-1alpha is an IL-1RI agonist with proinflammatory action, that acts primarily as an intracellular transcriptional regulator; it is not found in high concentration in the circulation. In contrast, IL-1beta can be secreted from cells in large quantities and thus it is commonly found in serum and secretions. In general, IL-1beta acts synergistically with tumor necrosis factor (TNF)-alpha, activating proinflammatory responses in a wide range of cells and promoting the acute phase response [6]. For these reasons IL-1beta levels have been studied in relation to physical activity. However, the circulating concentration of IL-1beta is either unaffected by exercise, or it exhibits relatively small, delayed changes [1,2]. In contrast to minimal changes in serum circulating IL-1beta after exercise, there is evidence of increased local IL-1beta levels after exercise within skeletal muscle; this is most likely associated with response to micro-injury of skeletal muscle caused by intense physical activity [8]. Interestingly, Mahoney and colleagues [9] demonstrated that elevated gene expression of IL-1RI is induced in skeletal muscle after eccentric exercise. Inflammatory and chemoattractant mediators likely promote phagocytosis of trauma-induced cellular debris by macrophages and these cells can continue to secrete IL-1beta up to 5 days post-injury [8]. It is of note that accumulation and activation of muscle resident macrophages is a rich source of growth factors postulated to stimulate myogenesis [4]. Thus, inflammation may serve as a mechanism promoting hypertrophy. However, pre- and post-exercise levels of inflammatory factors display considerable variation among people, and this is likely influenced, at least partially, by genetic variation [10,11].
###end p 10
###begin p 11
###xml 83 85 80 82 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B12">12</xref>
###xml 653 655 633 635 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B12">12</xref>
###xml 656 658 636 638 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B14">14</xref>
###xml 1056 1057 1030 1031 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B6">6</xref>
###xml 1058 1060 1032 1034 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B15">15</xref>
###xml 1241 1243 1212 1214 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B15">15</xref>
###xml 1244 1246 1215 1217 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B16">16</xref>
###xml 1394 1396 1362 1364 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B17">17</xref>
###xml 1527 1528 1489 1490 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B7">7</xref>
###xml 1529 1531 1491 1493 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B18">18</xref>
IL-1beta plays an important role in the regulation of acute inflammatory response [12]. After an insult to the body, IL-1beta is one of the first pro-inflammatory cytokines to be activated. Intense physical activity can cause micro-injury to skeletal muscle, and cytokines such as IL-1beta and TNF-alpha are thought to initiate and regulate the repair process. IL-1beta is able to induce the secretion of several inflammatory factors, such as IL-6, IL-8, TNF-alpha, and GM-CSF, by many different cell types including myoblasts, smooth and skeletal muscle cells, fibroblasts, macrophages, peripheral blood mononuclear cells (PBMC) and endothelial cells [12-14]. IL-1beta binds IL-1RI on the surface of a variety of cells and initiates a cascade of events leading to recruitment and activation of macrophages and neutrophils. However, inflammation must be strictly regulated to avoid secondary tissue damage and myopathy. The activity of IL-1beta is modulated mainly by a receptor antagonist (IL-1ra) that inhibits IL-1 action by competing for its receptor [6,15]. In healthy individuals, IL-1ra is easily detectable in plasma (concentrations are hundreds of pg/mL), but IL-1beta levels are usually undetectable (very few or less than pg/mL) [15,16]. In general, after an insult to the body both IL-1beta and IL-1ra increase, and thus, plasma levels of these cytokines are positively correlated [17]. However, the final inflammatory activity of IL-1beta is considered to be dependent on the actual ratio of IL-1beta over IL-1ra [7,18].
###end p 11
###begin p 12
###xml 108 110 108 110 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B14">14</xref>
###xml 111 113 111 113 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B19">19</xref>
###xml 175 180 172 177 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL-1B</italic>
###xml 194 200 191 197 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL-1RN</italic>
###xml 250 259 247 256 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro </italic>
###xml 260 262 257 259 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B14">14</xref>
###xml 263 265 260 262 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B20">20</xref>
###xml 271 279 268 276 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo </italic>
###xml 280 282 277 279 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B10">10</xref>
###xml 283 285 280 282 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B16">16</xref>
###xml 286 288 283 285 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B21">21</xref>
###xml 289 291 286 288 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B22">22</xref>
###xml 357 359 354 356 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B12">12</xref>
###xml 756 757 753 754 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B6">6</xref>
###xml 758 760 755 757 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B12">12</xref>
###xml 761 763 758 760 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B17">17</xref>
###xml 764 766 761 763 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B19">19</xref>
###xml 767 769 764 766 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B21">21</xref>
###xml 770 772 767 769 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B23">23</xref>
###xml 773 775 770 772 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B31">31</xref>
###xml 832 838 829 835 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL-1B </italic>
###xml 929 931 926 928 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B32">32</xref>
###xml 974 979 971 976 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TaqI </italic>
###xml 1011 1013 1008 1010 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B18">18</xref>
###xml 1080 1087 1077 1084 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL-1RN </italic>
###xml 1283 1284 1280 1281 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B6">6</xref>
###xml 1285 1287 1282 1284 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B18">18</xref>
###xml 1288 1290 1285 1287 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B19">19</xref>
###xml 1291 1293 1288 1290 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B29">29</xref>
###xml 1294 1296 1291 1293 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B33">33</xref>
###xml 1297 1299 1294 1296 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B34">34</xref>
###xml 337 342 <span type="species:ncbi:9606">human</span>
There is evidence that susceptibility to inflammation is influenced by genetic variation in cytokine genes [14,19]. Several studies showed that polymorphisms in the IL-1beta (IL-1B) and IL-1ra (IL-1RN) genes correlate with altered protein expression in vitro [14,20] and in vivo [10,16,21,22]. These two genes map close to each other on human chromosome 2 [12]. Polymorphisms in the IL-1 gene cluster associate with many clinical conditions, including inflammatory and infectious diseases (periodontal and arterial diseases, altered metabolic conditions, type 2 diabetes, type 2 diabetes complications, gastric cancer, rheumatoid arthritis, ankylosing spondylitis, systemic inflammation, myopathies, Alzheimer's disease, malaria, and bacterial vaginosis) [6,12,17,19,21,23-31]. Mostly, two single nucleotide polymorphisms (SNPs) in IL-1B have been studied for disease predisposition, one at position -511 in the promoter region [32] and another at position +3954 in exon 5 (TaqI restriction site polymorphism) [18]. In addition, a pentaallelic polymorphic site in intron 2 of the IL-1RN gene consisting in a variable number tandem repeats (VNTR, 86 bp repeats) has been extensively investigated in relation to a variety of pathological conditions, including inflammatory myopathies [6,18,19,29,33,34].
###end p 12
###begin p 13
###xml 195 200 195 200 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL-1A</italic>
###xml 208 213 208 213 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL-1B</italic>
###xml 220 225 220 225 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL-1B</italic>
###xml 237 243 237 243 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL-1B </italic>
###xml 287 293 287 293 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL-1B </italic>
###xml 321 328 321 328 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL-1RN </italic>
###xml 429 431 429 431 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B10">10</xref>
Recently, a study performed on 24 sedentary subjects (of unspecified ethnicity) selected on the basis of their haplotype pattern in the IL-1 gene cluster (based on specific combinations of +4845 IL-1A, +3954 IL-1B, -511 IL-1B, and -3737 IL-1B polymorphisms) showed that subjects C/C for IL-1B +3954 who carry allele 2 at IL-1RN +2018 were associated with the inflammation of skeletal muscle, following acute resistance exercise [10].
###end p 13
###begin p 14
###xml 229 234 226 231 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL-1B</italic>
###xml 257 264 254 261 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL-1RN </italic>
###xml 620 622 617 619 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B35">35</xref>
###xml 623 625 620 622 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B36">36</xref>
The aim of this study was to investigate whether polymorphisms in the IL-1beta and IL-1ra genes affect athletic status, competitive athlete vs. non-athlete. We evaluated whether the genotype frequencies of -511 and +3954 SNPs of IL-1B, and intron 2 VNTR of IL-1RN vary between athletes and non-athletes. Athletes of National or Regional competitive standard were recruited. This analysis was performed in a relatively homogeneous ethnic group of Caucasian Italian subjects because associations between polymorphisms in immune system-related genes may be confounded by allele frequency differences between ethnic groups [35,36]. We examined whether the polymorphisms of these genes are associated with being a professional (high-grade) or non-professional (medium-grade) athlete.
###end p 14
###begin title 15
methods
###end title 15
###begin title 16
Subjects and biological samples
###end title 16
###begin p 17
###xml 1081 1093 <span type="species:ncbi:9606">participants</span>
The study population consisted of subjects attending the Galeazzi Hospital for routine blood testing. Exclusion criteria were age younger than 18 years and presence of a pathologic condition or chronic major diseases such as diabetes, autoimmune diseases, cardiovascular diseases and malignancies. Athletes were enrolled from teams of Italian professional or non-professional athletes during routine physical examinations. Controls were recruited from the general Italian population of unrelated subjects after the following questions: 1) are you or have you ever been a trained athlete?; 2) did you ever participate in an official athletic competition? All control subjects were without any competitive sport experience, they declared they had never been an athlete or participated in any athletic competition or athletic training. All subjects were Caucasian. The study was approved by the Institutional Review Board of Milan Azienda Sanitaria Locale (ASL). The methods used in this study were in accordance with the Helsinki Declaration of 1975 as revised in 1996. All eligible participants were enrolled consecutively after written informed consent.
###end p 17
###begin p 18
Out of 688 subjects enrolled, 25 subjects were excluded from the study because 14 did not fulfill inclusion criteria and 11 had non-interpretable laboratory data. The final analyses were performed on 663 subjects, including 205 (30.9%) athletes and 458 (69.1%) non-athlete controls. The study population of 205 athletes included 53 high-grade professionals (50 current and 3 who had been professional athletes) who compete(d) at National level and 152 medium-grade non-professional athletes who participate in Regional athletic competitions. Specifically, high-grade athletes group included National Italian team grade (some of these athletes participated in Olympic Games, and some were medallists in International Games) or Third Division soccer players. The "caliber" of an Italian Third Division soccer team is similar to National teams of several European countries. The non-professional athlete group included athletes who are highly involved in sports activities (training and competitions >10 h/week).
###end p 18
###begin p 19
Among the athletes there were 139 females and 66 males. Age range of study athletes was 18-53 years. A total of 458 healthy Italian non-athlete subjects of both sexes in the age range of 18-53 years (mean 33.6 +/- 9.23 years) constituted the control group.
###end p 19
###begin p 20
###xml 260 262 260 262 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">g </italic>
###xml 133 138 <span type="species:ncbi:42554">tetra</span>
Blood samples were obtained from seated and fasting subjects in the morning from the antecubital vein with evacuated ethylenediamine tetra acetic acid (EDTA) tubes (Vacutainer Tubes, Becton-Dickinson, Franklin Lakes, NJ, USA). Samples were centrifuged at 2000 g for 10 min at 4degreesC and the cellular pellet was processed for DNA extraction. Personnel isolating and processing the DNA were blinded to the subjects' demographic characteristics.
###end p 20
###begin title 21
###xml 0 6 0 6 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL-1B </italic>
###xml 10 17 10 17 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL-1RN </italic>
IL-1B and IL-1RN polymorphisms gene identification
###end title 21
###begin p 22
Genomic DNA was extracted from the blood pellet fraction according to the standard proteinase-K digestion and ethanol extraction method. The extracted DNA was then stored at -20degreesC until further analysis.
###end p 22
###begin p 23
###xml 35 37 35 37 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B37">37</xref>
###xml 63 69 63 69 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL-1B </italic>
###xml 181 183 181 183 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B32">32</xref>
###xml 396 401 372 377 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">AvaI </italic>
###xml 608 610 578 580 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B31">31</xref>
To examine the -511 SNP (rs16944) [37], the promoter region of IL-1B was amplified by PCR, using the primers 5'-TGGCATTGATCTGGTTCATC-3' and 5'-GTTTAGGAATCTTCCCACTT-3' as described [32]. The protocol included 35 cycles at 94degreesC for 1 min, 55degreesC for 30 s, and 72degreesC for 30 s, and a final extension at 72degreesC of 5 min. At the end of the procedure the amplicons were digested with AvaI at 37degreesC for 3 hours. Fragments were analyzed after electrophoresis on 10% acrylamide gels and visualized with ethidium bromide. This gave products of 190 bp and 114 bp (C allele) or 304 bp (T allele) [31]. Out of 663 study subjects, 4 data were not available for the -511 genotype.
###end p 23
###begin p 24
###xml 36 38 36 38 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B37">37</xref>
###xml 92 97 92 97 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TaqI </italic>
###xml 154 156 154 156 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B30">30</xref>
###xml 261 263 261 263 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B18">18</xref>
###xml 305 310 305 310 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TaqI </italic>
###xml 582 584 576 578 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B31">31</xref>
To determine the +3954 (rs1143634) [37] SNP genotype, the polymorphic region containing the TaqI restriction site (designed as +3953 in older literature [30]) was amplified using the following primers: 5'-GTTGTCATCAGACTTTGACC-3' and 5'-TTCAGTTCATATGGACCAGA-3' [18]. The 249 bp products were digested with TaqI at 65degreesC for 1 hour, resulting in fragments that either remained intact (T allele) or were digested into 2 fragments of 135 and 114 bp (C allele). The restriction fragments were analyzed by electrophoresis on 10% acrylamide gels and visualized with ethidium bromide [31].
###end p 24
###begin p 25
###xml 4 11 4 11 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL-1RN </italic>
###xml 50 52 50 52 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B38">38</xref>
###xml 137 139 137 139 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B18">18</xref>
###xml 140 142 140 142 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B33">33</xref>
###xml 340 342 340 342 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B18">18</xref>
###xml 429 431 429 431 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B31">31</xref>
The IL-1RN intron 2 VNTR polymorphism (rs380092) [38] was analyzed using 5'-CTCAGCAACACTCCTAT-3' and 5'-TCCTGGTCTGCAGGTAA-3' as primers [18,33]. The PCR products of 410 bp (allele 1 = 4 repeats of the 86 bp region), 240 bp (allele 2 = 2 repeats), 500 bp (allele 3 = 5 repeats), 325 bp (allele 4 = 3 repeats), 595 bp (allele 5 = 6 repeats) [18] were analyzed by electrophoresis on 8% acrylamide gel stained with ethidium bromide [31]. A blinded quality control was performed in a random subset of 20 samples, which were sequenced by use of ABI Prism 310 genetic analyzer (Applied Biosystems). The sample consisted of 11 subjects 1/1, 6 subjects 1/2, and 3 subjects 2/2 genotype; a 100% correspondence with gel data was obtained.
###end p 25
###begin title 26
Statistical analysis
###end title 26
###begin p 27
###xml 217 219 217 219 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B39">39</xref>
###xml 594 596 594 596 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B40">40</xref>
###xml 729 735 729 735 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL-1RN</italic>
###xml 892 894 892 894 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B41">41</xref>
###xml 949 955 949 955 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL-1B </italic>
###xml 994 1001 994 1001 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL-1RN </italic>
###xml 1033 1035 1033 1035 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B42">42</xref>
###xml 1335 1336 1335 1336 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 1437 1438 1437 1438 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
The genotype frequencies for each polymorphism were compared by 2-sided Pearson chi-square or Fisher's exact test as appropriate, using STATA statistical software version 10, College Station, TX, USA and Powermarker [39]. The odds ratio (OR) and the 95% confidence interval (CI) were calculated to evaluate the genotype effects of each genotype against all others. Tests for deviations from Hardy-Weinberg equilibrium (HWE) were performed in Powermarker, using a chi-square distribution in cases and controls separately for each SNP. Haplotype analysis was performed with the program Unphased [40]. Haplotypes estimated to be below 1% in frequency were not reported. Due to the low allele frequencies of the 3, 4 and 5 allele of IL-1RN, the intron 2 VNTR genotypes were grouped into the short allele (S, allele 2) and the long alleles (L, alleles 1, 3, 4, and 5) according to Machado et al. [41]. Linkage disequilibrium (LD) between the two SNPs in IL-1B and the VNTR short and long alleles in IL-1RN was determined using Haploview [42]. Differences in the haplotype distributions between cases and controls were determined by likelihood ratio tests. The reference distribution for which all the other haplotypes were compared against was the most common haplotype. The OR was considered significant if the CI did not cross unity. The P-value for each haplotype was determined by comparing the haplotype against all others. Therefore, a P-value may be slightly significant even if the OR is not.
###end p 27
###begin title 28
Results
###end title 28
###begin p 29
###xml 426 427 426 427 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="T1">1</xref>
The study population consisted of 205 athletes; of these 53 were professional (high-grade, National level) and 152 were non-professional (medium-grade, Regional level, recreational athletes not paid for performing competitions) athletes regularly participating in athletic competitions. Controls were 458 healthy non-athletes. Demographic characteristics and sport disciplines practiced by the 205 athletes are shown in Table 1.
###end p 29
###begin p 30
Demographic characteristics and sport activities of 205 study athletes.
###end p 30
###begin p 31
###xml 0 1 0 1 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">a</sup>
a4 were professional athletes
###end p 31
###begin p 32
###xml 0 1 0 1 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">b</sup>
b48 were professional athletes
###end p 32
###begin p 33
###xml 0 1 0 1 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">c</sup>
c22 were professional athletes
###end p 33
###begin p 34
###xml 0 1 0 1 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">d</sup>
d23 were professional athletes
###end p 34
###begin p 35
###xml 0 1 0 1 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">e</sup>
e8 were professional athletes
###end p 35
###begin p 36
###xml 70 76 70 76 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL-1B </italic>
###xml 108 115 108 115 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL-1RN </italic>
A total of 663 study subjects were genotyped for the three gene loci (IL-1B in position -511 and +3954; and IL-1RN intron 2 VNTR).
###end p 36
###begin p 37
###xml 154 161 154 161 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL-1RN </italic>
###xml 162 164 162 164 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P </italic>
###xml 219 221 219 221 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P </italic>
###xml 296 302 296 302 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL-1B </italic>
###xml 486 487 486 487 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="T2">2</xref>
###xml 560 562 560 562 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P </italic>
Neither case nor control samples deviated from Hardy Weinberg equilibrium (HWE) at site -511 or site +3954. The controls deviated from HWE at the VNTR in IL-1RN (P = 0.001); while athletes marginally deviated from HWE (P = 0.097). Athletes and controls did not differ in the distribution of -511 IL-1B genotypes; 38.8% athletes vs. 44.8% controls were homozygous CC, 48.8% athletes vs. 45.9% controls were heterozygous CT, and 12.4% athletes vs. 9.4% controls were homozygous TT (Table 2). The two groups also did not differ significantly in allele frequency (P = 0.11).
###end p 37
###begin p 38
###xml 24 30 24 30 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL-1B </italic>
Genotype frequencies of IL-1B promoter at position -511 in 659 white subjects, comparison of 201 athletes and 458 non-athlete controls.
###end p 38
###begin p 39
###xml 36 42 36 42 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL-1B </italic>
###xml 85 86 85 86 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="T3">3</xref>
###xml 362 364 362 364 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P </italic>
Genotype and allele distribution of IL-1B +3954 gene polymorphism are shown in Table 3. Athletes and controls did not differ; 60.0% athletes vs. 62.2% controls were homozygous CC, 36.1% athletes vs. 32.3% controls were heterozygous CT, and 3.9% athletes vs. 5.5% controls were homozygous TT. The two groups also did not differ significantly in allele frequency (P = 0.89).
###end p 39
###begin p 40
###xml 24 30 24 30 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL-1B </italic>
Genotype frequencies of IL-1B exon 5 at position +3954 in 663 subjects, comparison of 205 athletes and 458 non-athlete controls.
###end p 40
###begin p 41
###xml 8 15 8 15 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL-1RN </italic>
###xml 307 313 307 313 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL-1RN</italic>
###xml 389 391 389 391 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P </italic>
###xml 438 444 438 444 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL-1RN</italic>
###xml 523 525 523 525 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P </italic>
###xml 544 550 544 550 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL-1RN</italic>
###xml 601 603 601 603 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P </italic>
###xml 629 631 629 631 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P </italic>
###xml 647 648 647 648 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="T4">4</xref>
###xml 1232 1233 1232 1233 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="S1">1</xref>
For the IL-1RN VNTR polymorphism three alleles (allele 1, 2 and 3) were common in our study; allele 4 was found in 3 subjects (one genotype 1/4 and two genotypes 2/4, all in the control group) and allele 5 was detected in only 1 subject (one genotype 1/5, in the athlete group). The most common allele, the IL-1RN*1 allele, was less frequent in athletes than in controls (65.4% vs. 74.0%, P = 0.001), whereas the second commonest allele, IL-1RN*2, had an allele frequency higher in athletes than controls (32.2% vs. 22.9%, P < 0.001), finally, IL-1RN*3 had similar frequency in athletes and controls (P = 0.57) (overall alleles, P = 0.001) (Table 4). Specifically, athletes were less likely to have the 1/1 genotype (OR = 0.55, 95% CI 0.40-0.77), and 2-fold more likely to be 1/2 (OR = 1.93, 95% CI 1.37-2.74). Athletes and controls did not differ in frequency of the 2/2 genotype. However, we observed increased frequencies of cumulative 1/2, 2/2, 2/3 and 2/4 genotypes in athletes (53.7%) compared with controls (36.7%), OR = 2.00 (95% CI = 1.43-2.79), suggesting a dominant effect of the 2 allele. These observations were significant in both male and female athletes when analyzed separately (data not shown, see additional File 1). Genotypes that included the 3 allele did not differ between athletes and controls.
###end p 41
###begin p 42
###xml 24 31 24 31 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL-1RN </italic>
Genotype frequencies of IL-1RN VNTR, comparison of 205 athletes and 458 non-athlete controls.
###end p 42
###begin p 43
###xml 31 32 31 32 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="T5">5</xref>
###xml 47 54 47 54 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL-1RN </italic>
In a secondary analysis (Table 5), we compared IL-1RN genotypes between the 53 professional athletes and the 152 non-professional athletes. Interestingly, we found that the 1/2 VNTR genotype was almost 2-fold more frequent in professional than in non-professional athletes (OR = 1.92, 95% CI = 1.02-3.61). No other significant differences were noted between professional and recreational athletes.
###end p 43
###begin p 44
###xml 24 31 24 31 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL-1RN </italic>
Genotype frequencies of IL-1RN VNTR comparison of 53 professional athletes and 152 non-professional athletes and 458 non-athlete controls.
###end p 44
###begin p 45
###xml 0 1 0 1 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">a</sup>
aComparison between professional and non-professional athletes
###end p 45
###begin p 46
###xml 0 1 0 1 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">b</sup>
bComparison between professional athletes and non-athlete controls
###end p 46
###begin p 47
###xml 0 1 0 1 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">c</sup>
cComparison between non-professional athletes and non-athlete controls
###end p 47
###begin p 48
###xml 173 174 173 174 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="T5">5</xref>
###xml 325 326 325 326 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="T5">5</xref>
###xml 605 606 605 606 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="T4">4</xref>
Comparison of professional athletes with non-athletes revealed that genotype 1/2 VNTR was 3-fold more frequent in high-grade athletes (OR = 3.12, 95% CI = 1.75-5.56) (Table 5). The same genotype was only 1.6-fold more frequent in medium grade/recreational athletes than in non-athletes (OR = 1.62, 95% CI = 1.10-2.40) (Table 5). The 1/1 genotype was 2.5-fold more frequent in non-athletes than in professional athletes (OR = 2.52, 95% CI = 1.40-4.56), but 1.6-fold more frequent in non-athletes than in recreational athletes (OR = 1.61, 95% CI = 1.11-2.33). Overall (frequencies already reported in Table 4), the 1/1 genotype was 1.8-fold more frequent in non-athletes than in all athletes (OR = 1.80, 95% CI = 1.29-2.51).
###end p 48
###begin p 49
###xml 72 73 72 73 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="T6">6</xref>
###xml 153 154 153 154 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F1">1</xref>
###xml 174 176 174 176 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2 </sup>
###xml 194 195 192 193 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F2">2</xref>
###xml 285 287 283 285 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P </italic>
Haplotype analyses were performed, using all three polymorphisms (Table 6). There was virtually no LD between any of the three sites in athletes (Figure 1) or non-athletes (r2 </= 0.05) (Figure 2). The three site haplotype was differentially distributed between athletes and controls (P = 0.012). Individually only one haplotype associated with athlete status. Specifically, (-511)C-(+3954)T-(VNTR)2 was 3 times more common in athletes than non-athletes (OR = 3.02, 95%CI = 1.15-7.87). We also analyzed the three pair wise haplotypes and found that only those that included the VNTR were significant, indicating that the association was related to the VNTR or a marker in linkage disequilibrium with it.
###end p 49
###begin p 50
###xml 31 32 31 32 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 0 56 0 56 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Linkage disequilibrium plots (r<sup>2</sup>) are shown for athletes</bold>
Linkage disequilibrium plots (r2) are shown for athletes.
###end p 50
###begin p 51
###xml 31 32 31 32 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 0 60 0 60 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Linkage disequilibrium plots (r<sup>2</sup>) are shown for non-athletes</bold>
Linkage disequilibrium plots (r2) are shown for non-athletes.
###end p 51
###begin p 52
Haplotype frequencies in athletes and non-athlete controls.
###end p 52
###begin p 53
###xml 0 1 0 1 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">a</sup>
###xml 82 89 82 89 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL-1RN </italic>
aDue to the low allele frequencies of the 3, 4 and 5 alleles of the intron 2 VNTR IL-1RN genotypes were grouped into the short allele (S, allele 2) and the long alleles (L, alleles 1, 3, 4, and 5).
###end p 53
###begin title 54
Discussion
###end title 54
###begin title 55
Polymorphisms and exercise
###end title 55
###begin p 56
Our finding that athletes have significantly different genotypes than non-athletes reinforces the evidence that athletic performance is associated with genetic constitution in addition to environmental/behavioral factors. However, we want to emphasize that carriage of a specific genetic polymorphism is only a predisposing factor and does not by itself necessarily result in elite performance. Clearly, more than one biologic process is necessary for the development of high-grade athletic performance.
###end p 56
###begin p 57
###xml 204 206 204 206 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B43">43</xref>
###xml 437 439 433 435 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B44">44</xref>
###xml 440 442 436 438 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B46">46</xref>
###xml 498 500 494 496 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B45">45</xref>
###xml 568 575 560 567 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL-15RA</italic>
###xml 746 748 738 740 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B47">47</xref>
###xml 929 931 921 923 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B48">48</xref>
###xml 983 985 975 977 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B49">49</xref>
###xml 1021 1023 1013 1015 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B50">50</xref>
###xml 665 668 <span type="species:ncbi:9606">men</span>
###xml 676 681 <span type="species:ncbi:9606">women</span>
###xml 1184 1189 <span type="species:ncbi:9606">women</span>
In general, genetic associations of athletic phenotype are only partially understood. Increased knowledge in this research may help to identify physiological and biochemical pathways related to exercise [43]. Genetic studies so far focused on candidate genes (over 200) mainly involved in cardiovascular performance, including angiotensin-converting enzyme (ACE) and proteins involved in skeletal-muscle activity such as alpha-actinins [44-46]. Immunity-related genes have been minimally explored [45]. A study that examined polymorphisms of the IL-15 receptor-alpha (IL-15RA) gene identified a SNP strongly associated with muscle hypertrophy in young subjects (76 men and 77 women) of mixed ethnicity who performed resistance exercise training [47]. Two studies performed in non-athletes reported that the -174G/C variant in the IL-6 gene affected the response to exercise by modulating changes in serum concentrations of IL-6 [48] and high-density lipoprotein cholesterol (HDL-C) [49]. However, Walston and colleagues [50] identified no significant relationship between IL-6 SNPs or IL-6 haplotypes and serum IL-6 concentration, grip, knee, or hip strength, or frailty in 463 older women.
###end p 57
###begin title 58
###xml 29 34 <span type="species:ncbi:9606">human</span>
IL-1beta and IL-1ra roles in human disease and exercise
###end title 58
###begin p 59
The inflammatory response after intensive exercise is a well documented phenomenon; the coordinated action of cytokines is considered crucial for regulation of inflammatory reactions responsible for immune defenses and muscle repair. Conceivably, a delay in the removal of dead cells increases the likelihood of a slow recovery.
###end p 59
###begin p 60
###xml 268 269 265 266 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B6">6</xref>
###xml 270 272 267 269 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B12">12</xref>
###xml 491 493 485 487 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B12">12</xref>
###xml 641 643 632 634 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B12">12</xref>
###xml 774 776 762 764 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B23">23</xref>
###xml 777 779 765 767 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B51">51</xref>
###xml 837 839 825 827 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B52">52</xref>
###xml 840 842 828 830 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B53">53</xref>
###xml 1167 1168 1146 1147 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B7">7</xref>
###xml 1257 1259 1236 1238 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B54">54</xref>
###xml 1464 1471 1440 1447 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL-1RN </italic>
###xml 1475 1481 1451 1457 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL-1B </italic>
###xml 1488 1490 1464 1466 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B16">16</xref>
###xml 1491 1493 1467 1469 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B22">22</xref>
###xml 1849 1850 1825 1826 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B6">6</xref>
###xml 1851 1852 1827 1828 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B7">7</xref>
###xml 1853 1855 1829 1831 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B51">51</xref>
###xml 1856 1858 1832 1834 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B55">55</xref>
###xml 721 726 <span type="species:ncbi:9606">human</span>
###xml 1643 1649 <span type="species:ncbi:9606">humans</span>
IL-1beta is a crucial proinflammatory cytokine involved in initiating and amplifying the inflammatory response; it stimulates the production of prostaglandins and nitric oxide, both of which are highly inflammatory, and it induces the synthesis of several chemokines [6,12]. IL-1beta is a highly active pleiotropic cytokine with several known functions. It has many systemic effects in the protection of the body, including response to stress and the metabolism of insulin, lipids and bone [12]. Injecting a few nanograms per kilogram of IL-1beta results in an increase of acute phase proteins, plasma IL-6, neutrophilia and thrombocytosis [12]. Recent evidence suggests that IL-1beta plays a key pathogenic role in many human conditions, including cardiovascular diseases [23,51], and in the central nervous system effects of exercise [52,53]. The bioactivity of IL-1beta is finely modulated as it is a potentially harmful factor able to promote tissue damage and fever. The main cytokine that counteracts the effects of IL-1beta is IL-1ra, a naturally occurring inhibitor of IL-1beta that binds to IL-1 receptor type I, but does not elicit post-receptor signaling [7]. In addition, IL-1ra seems to modulate the IL-1 decoy receptor, IL-1 receptor type II [54]. IL-1ra protein is produced by many cells that can synthesize IL-1beta, mainly by hepatocytes, adipocytes, neutrophils and macrophages. The IL-1ra plasma levels are co-coordinately regulated by both the IL-1RN and IL-1B genes [16,22]. The biological functions of IL-1ra are not completely understood. Interestingly, at present a recombinant IL-1ra (anakinra) is approved for use in humans as an anti-inflammatory therapy in several conditions, such as rheumatic diseases, ankilosing spondylitis, chronic Achilles tendinopathy, type 2 diabetes mellitus and systemic inflammatory diseases [6,7,51,55].
###end p 60
###begin p 61
###xml 151 152 148 149 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B1">1</xref>
###xml 153 154 150 151 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B5">5</xref>
###xml 349 350 343 344 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B1">1</xref>
###xml 615 616 609 610 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B1">1</xref>
Several studies found that serum IL-1beta concentration does not change after physical exercise, whereas IL-1ra concentration significantly increases [1,5]. In this respect, the profile of systemic cytokines' changes in response to exercise differs from that observed in sepsis, where there is a relevant increase in both serum IL-1beta and IL-1ra [1]. The rise of circulating anti-inflammatory cytokines induced by exercise has been suggested as one of the pathways involved in protection against several diseases, primarily against cardiovascular disease and type 2 diabetes mellitus exerted by regular exercise [1].
###end p 61
###begin title 62
###xml 41 48 41 48 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL-1RN </italic>
VNTR polymorphism in the intron 2 of the IL-1RN gene
###end title 62
###begin p 63
###xml 85 91 85 91 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL-1B </italic>
###xml 177 185 177 185 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo </italic>
###xml 305 306 299 300 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B1">1</xref>
###xml 307 308 301 302 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B9">9</xref>
###xml 309 311 303 305 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B56">56</xref>
We demonstrated that the genotype -511 in the promoter region and +3954 in exon 5 of IL-1B gene have no influence on the athletic phenotype. These findings seem to fit with the in vivo observation that neither circulating IL-1beta, nor IL-1beta mRNA levels are significantly changed by physical activity [1,9,56].
###end p 63
###begin p 64
###xml 96 102 96 102 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL-1RN</italic>
###xml 235 242 235 242 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL-1RN </italic>
###xml 429 436 429 436 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL-1RN </italic>
In contrast, we showed that a specific genotype (1/2) of the IL-1ra gene, a VNTR in intron 2 of IL-1RN, is almost 2-fold more frequent in athletes than in non-athletes. Additionally, we observed a dose-effect relationship with the 1/2 IL-1RN genotype being 2-fold more frequent in professional than in recreational athletes and 3-fold more frequent in professional athletes than in non-athletes. Thus, our study suggests the 1/2 IL-1RN frequency is increasing in parallel with the level of athletic grade. We did not observe gender effects.
###end p 64
###begin p 65
###xml 37 44 37 44 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL-1RN </italic>
###xml 80 82 80 82 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B22">22</xref>
###xml 83 85 83 85 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B27">27</xref>
###xml 106 113 106 113 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL-1RN </italic>
###xml 236 237 236 237 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B4">4</xref>
###xml 238 240 238 240 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B47">47</xref>
###xml 331 333 331 333 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B22">22</xref>
###xml 334 336 334 336 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B27">27</xref>
###xml 372 378 372 378 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL-1RN</italic>
###xml 558 560 558 560 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B19">19</xref>
###xml 561 563 561 563 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B27">27</xref>
###xml 633 639 633 639 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL-1RN</italic>
###xml 690 696 690 696 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL-1RN</italic>
###xml 741 743 741 743 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B14">14</xref>
###xml 744 746 744 746 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B57">57</xref>
###xml 747 749 747 749 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B58">58</xref>
###xml 795 797 795 797 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B29">29</xref>
###xml 825 827 825 827 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B16">16</xref>
###xml 828 830 828 830 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B18">18</xref>
###xml 831 833 831 833 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B21">21</xref>
###xml 981 988 981 988 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL-1RN </italic>
###xml 994 996 994 996 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B27">27</xref>
###xml 323 329 <span type="species:ncbi:9606">humans</span>
The precise molecular effects of the IL-1RN polymophisms are not totally clear [22,27]. Possibly, the 1/2 IL-1RN genotype could favor muscle repair and hypertrophy in athletes; however, further studies are needed to clarify this issue [4,47]. This can occur through an influence on circulating or local levels of IL-1ra in humans [22,27]. Consistent with this is that the IL-1RN*2 allele is associated with a higher production of inflammatory reactions, and therefore, an overall increase of IL-1 activity, meaning less effective IL-1ra inhibitory activity [19,27]. However, contrasting findings were obtained for the association of IL-1RN*2 with IL-1ra levels; some authors found that the IL-1RN*2 allele is associated with reduced IL-1ra [14,57,58], but other authors observed no association [29] or even increased IL-1ra [16,18,21]. Some of these discrepancies can be due to different experimental designs and/or by the presence of heterogeneity with other polymorphisms in the IL-1RN gene [27].
###end p 65
###begin p 66
###xml 189 191 189 191 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B18">18</xref>
###xml 192 194 192 194 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B19">19</xref>
###xml 195 197 195 197 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B26">26</xref>
###xml 198 200 198 200 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B28">28</xref>
###xml 201 203 201 203 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B34">34</xref>
###xml 204 206 204 206 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B59">59</xref>
###xml 207 209 207 209 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B60">60</xref>
###xml 235 242 235 242 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL-1RN </italic>
###xml 304 311 304 311 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL-1RN </italic>
###xml 359 361 359 361 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B19">19</xref>
###xml 362 364 362 364 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B34">34</xref>
###xml 365 367 365 367 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B41">41</xref>
###xml 383 392 383 392 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro </italic>
###xml 482 484 482 484 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B14">14</xref>
###xml 485 487 485 487 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B58">58</xref>
###xml 528 530 525 527 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B20">20</xref>
###xml 678 685 675 682 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL-1RN </italic>
###xml 776 783 773 780 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL-1RN </italic>
In our study athletes were not more likely to be homozygous for the allele 2, a genotype that has been associated with several pathological conditions of inflammatory or autoimmune nature [18,19,26,28,34,59,60]. It is of note that the IL-1RN 2/2 genotype was more likely associated with disease than the IL-1RN 1/2, especially for gastric cancer development [19,34,41]. Based on the in vitro observation that VNTR allele 2 has been associated with a decreased production of IL-1ra [14,58]; and increased production of IL-1beta [20] in a dose-dependent fashion, these findings, taken together, suggest that a moderate increase of IL-1-dependent inflammation, as conferred by one IL-1RN allele 2 can favor athletic performance, but not an excessive increase as conferred by the IL-1RN 2/2 genotype.
###end p 66
###begin p 67
###xml 149 151 149 151 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B35">35</xref>
It is known that there are different IL-1 gene cluster genetic profiles between ethnic groups, and particularly between black and white populations [35]. Therefore, we considered only white Italian subjects, a homogeneous Caucasian ethnic group. A limitation of this approach is that our results may not be applicable to non-Caucasian subjects.
###end p 67
###begin title 68
Conclusions
###end title 68
###begin p 69
###xml 204 210 204 210 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL-1RN</italic>
###xml 397 404 397 404 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL-1RN </italic>
Our study supports the notion that the IL-1 family of genes is significantly associated with physical performance. The finding of a higher frequency of allele 2, and specifically of the 1/2 genotype VNTR IL-1RN, in athletes with respect to non-athletes highlights that immune genetic variants are involved in athletic predisposition. Based on previous evidence of inflammatory effects of the VNTR IL-1RN allele 2, the association of IL-1 related genes with athlete status appears to associate a genetic predisposition of a moderately enhanced inflammatory response. However, we cannot exclude much more indirect effects modulated by IL-1ra. Immunity in physical exercise is likely regulated by subtle tuning of cytokine levels; for example, a partial reduction in IL-1ra could reinforce immune defenses against exercise-associated micro-injuries.
###end p 69
###begin p 70
###xml 522 529 522 529 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL-1RN </italic>
###xml 818 825 818 825 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL-1RN </italic>
It was beyond the scope of this study to investigate the effects of IL-1 polymorphisms on exercise-induced systemic and local inflammation, recovery capacity and type of sport activity (aerobic vs. anaerobic; endurance vs. sprint), which should be clarified in future studies. Of major interest will be the comparison of aerobic vs. anaerobic athletes; however, in the present study this kind of evaluation was not possible due to small number of athletes participating in purely anaerobic sports. Future studies relating IL-1RN genotypes and cytokine levels should focus preferably on immune genetic profiles and inflammatory markers evaluated before and after exercise. Although our results indicate an association between the IL-1 family of cytokines and athlete status, it is not clear how, specifically, the VNTR IL-1RN polymorphism affects the phenotype promoting a relationship between this allele and grade of athletic performance.
###end p 70
###begin p 71
###xml 42 48 42 48 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL-1B </italic>
###xml 71 78 71 78 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL-1RN </italic>
###xml 383 390 380 387 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL-1RN </italic>
###xml 432 434 429 431 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B61">61</xref>
###xml 226 231 <span type="species:ncbi:9606">human</span>
In this study we focused on 2 SNPs of the IL-1B gene and 1 VNTR in the IL-1RN gene because these are the most frequently studied polymorphisms of the IL-1beta and IL-1ra cytokines, which have been associated with a variety of human conditions. Interestingly, athlete status may constitute a confounding factor contributing to variability of results concerning the association of the IL-1RN polymorphisms with pathologic conditions [61].
###end p 71
###begin p 72
Our present results should prompt larger studies on additional polymorphisms in the IL-1 family in relation to physical performance and elite athletic grade, particularly, those located in the IL-1ra gene, as the SNP at position +2018.
###end p 72
###begin p 73
In conclusion, we demonstrated in a cross-sectional study that a polymorphism potentially able to modulate the levels of the IL-1ra cytokine, and indirectly IL-1 (alpha and beta) activity, is associated with athlete status. Further research into immune factors that increase athletic performance will help to inform the design of how immune modulators may improve recovery or implement cure interventions after injuries. Our finding suggests that clinical trials performed to assess efficacy of various treatments for athlete's recovery should probably differentiate subjects on a genetic basis in addition to etiology to maximize the chances of observing statistically significant and reproducible results. Our study suggests cytokines are important molecules to further explore in relation to sports activity. Overall, this study may contribute to an increased understanding of the genetic basis of athletic performance. It may also increase our understanding of inflammatory mechanisms associated with intensive exercise.
###end p 73
###begin title 74
Competing interests
###end title 74
###begin p 75
The authors declare that they have no competing interests.
###end p 75
###begin title 76
Authors' contributions
###end title 76
###begin p 77
Conceived and designed the experiments: SC. Performed the experiments: MDS, SC. Analyzed the data and performed statistical analysis: KKR, SMW. Wrote the paper: SC, SMW, GB. All authors read and approved the final manuscript.
###end p 77
###begin title 78
Pre-publication history
###end title 78
###begin p 79
The pre-publication history for this paper can be accessed here:
###end p 79
###begin p 80

###end p 80
###begin title 81
Supplementary Material
###end title 81
###begin title 82
Additional file 1
###end title 82
###begin p 83
###xml 32 38 32 38 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL-1B </italic>
###xml 125 131 125 131 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL-1B </italic>
###xml 217 224 217 224 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL-1RN </italic>
###xml 0 256 0 256 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Table 7 Genotype frequencies of <italic>IL-1B </italic>promoter at position -511 in female and male athletes. Table 8 Genotype frequencies of <italic>IL-1B </italic>exon 5 at position +3954 in female and male athletes. Table 9 Genotype frequencies of <italic>IL-1RN </italic>VNTR in female and male athletes</bold>
###xml 273 279 273 279 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL-1B </italic>
###xml 283 290 283 290 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL-1RN </italic>
Table 7 Genotype frequencies of IL-1B promoter at position -511 in female and male athletes. Table 8 Genotype frequencies of IL-1B exon 5 at position +3954 in female and male athletes. Table 9 Genotype frequencies of IL-1RN VNTR in female and male athletes. Frequencies of IL-1B and IL-1RN genotype frequencies stratified by athlete gender.
###end p 83
###begin p 84
Click here for file
###end p 84
###begin title 85
Acknowledgements
###end title 85
###begin p 86
Many thanks to Prof. Giuseppe Damante, Institute of Genetics, University Hospital of Udine, Udine, Italy for blinded quality control of genotyping.
###end p 86
###begin p 87
This study was supported in part by year 2006, 2007 grants from University of Udine.
###end p 87
###begin article-title 88
The anti-inflammatory effect of exercise
###end article-title 88
###begin article-title 89
Cytokine changes after a marathon race
###end article-title 89
###begin article-title 90
Immune function in sport and exercise
###end article-title 90
###begin article-title 91
Inflammatory processes in muscle injury and repair
###end article-title 91
###begin article-title 92
Plasma cytokine changes in relation to exercise intensity and muscle damage
###end article-title 92
###begin article-title 93
Immunological and inflammatory functions of the interleukin-1 family
###end article-title 93
###begin article-title 94
Interleukin-1beta and the autoinflammatory diseases
###end article-title 94
###begin article-title 95
Acute phase response in exercise. III. Neutrophil and IL-1 beta accumulation in skeletal muscle
###end article-title 95
###begin article-title 96
###xml 29 34 <span type="species:ncbi:9606">human</span>
Gene expression profiling in human skeletal muscle during recovery from eccentric exercise
###end article-title 96
###begin article-title 97
###xml 77 82 <span type="species:ncbi:9606">human</span>
Interleukin-1 polymorphisms are associated with the inflammatory response in human muscle to acute resistance exercise
###end article-title 97
###begin article-title 98
Evidence for genetic variation as a factor in maintaining health
###end article-title 98
###begin article-title 99
Biologic basis for interleukin-1 in disease
###end article-title 99
###begin article-title 100
Myoblasts produce IL-6 in response to inflammatory stimuli
###end article-title 100
###begin article-title 101
###xml 48 53 <span type="species:ncbi:9606">human</span>
Interleukin-1 receptor antagonist expression in human endothelial cells and atherosclerosis
###end article-title 101
###begin article-title 102
Blocking IL-1 in systemic inflammation
###end article-title 102
###begin article-title 103
IL-1 receptor antagonist (IL-1Ra) plasma levels are co-ordinately regulated by both IL-1Ra and IL-1beta genes
###end article-title 103
###begin article-title 104
IL-1B and IL-1Ra gene polymorphisms and disease severity in rheumatoid arthritis: interaction with their plasma levels
###end article-title 104
###begin article-title 105
Allelic polymorphism in IL-1 beta and IL-1 receptor antagonist (IL-1Ra) genes in inflammatory bowel disease
###end article-title 105
###begin article-title 106
Interleukin-1 polymorphisms associated with increased risk of gastric cancer
###end article-title 106
###begin article-title 107
Presence of the IL-1RA allele 2 (IL1RN*2) is associated with enhanced IL-1beta production in vitro
###end article-title 107
###begin article-title 108
###xml 78 81 <span type="species:ncbi:9606">men</span>
Interleukin-1 system gene polymorphisms are associated with fat mass in young men
###end article-title 108
###begin article-title 109
Common genetic variation in the gene encoding interleukin-1-receptor antagonist (IL-1RA) is associated with altered circulating IL-1RA levels
###end article-title 109
###begin article-title 110
The effect of interleukin-1 receptor antagonist on arteries and cholesterol metabolism
###end article-title 110
###begin article-title 111
Genetic association of interleukin-1beta (-511C/T) and interleukin-1 receptor antagonist (86 bp repeat) polymorphisms with Type 2 diabetes mellitus in North Indians
###end article-title 111
###begin article-title 112
###xml 90 98 <span type="species:ncbi:9606">patients</span>
Interleukin-1 receptor antagonist genotype is associated with coronary atherosclerosis in patients with type 2 diabetes
###end article-title 112
###begin article-title 113
Interleukin-1 receptor antagonist allele (IL1RN*2) associated with nephropathy in diabetes mellitus
###end article-title 113
###begin article-title 114
Polymorphisms of the IL1-receptor antagonist gene (IL1RN) are associated with multiple markers of systemic inflammation
###end article-title 114
###begin article-title 115
Interleukin-1beta and interleukin-1 receptor antagonist gene polymorphisms in ankylosing spondylitis
###end article-title 115
###begin article-title 116
Polymorphisms in the IL-1 receptor antagonist gene VNTR are possible risk factors for juvenile idiopathic inflammatory myopathies
###end article-title 116
###begin article-title 117
Interleukin-1 gene cluster polymorphisms and susceptibility to clinical malaria in a Gambian case-control study
###end article-title 117
###begin article-title 118
###xml 134 139 <span type="species:ncbi:9606">women</span>
Association of interleukin-1beta and interleukin-1 receptor antagonist polymorphisms with bacterial vaginosis in non-pregnant Italian women
###end article-title 118
###begin article-title 119
###xml 40 45 <span type="species:ncbi:9606">human</span>
Single base polymorphism at -511 in the human interleukin-1 beta gene (IL1 beta)
###end article-title 119
###begin article-title 120
###xml 16 21 <span type="species:ncbi:9606">human</span>
Polymorphism in human IL-1 receptor antagonist gene intron 2 is caused by variable numbers of an 86-bp tandem repeat
###end article-title 120
###begin article-title 121
Influence of interleukin-1 receptor antagonist gene polymorphism on disease
###end article-title 121
###begin article-title 122
Differences in the genotypes and plasma concentrations of the Interleukin-1 receptor antagonist in black and white South African asthmatics and control subjects
###end article-title 122
###begin article-title 123
###xml 41 46 <span type="species:ncbi:9606">human</span>
Genetic analysis of African populations: human evolution and complex disease
###end article-title 123
###begin article-title 124
###xml 113 121 <span type="species:ncbi:9606">patients</span>
Association of -31T>C and -511 C>T polymorphisms in the interleukin 1 beta (IL1B) promoter in Korean keratoconus patients
###end article-title 124
###begin article-title 125
IL1 gene cluster polymorphisms and its haplotypes may predict the risk to develop invasive pulmonary aspergillosis and modulate C-reactive protein level
###end article-title 125
###begin article-title 126
PowerMarker: an integrated analysis environment for genetic marker analysis
###end article-title 126
###begin article-title 127
Likelihood-based association analysis for nuclear families and unrelated subjects with missing genotype data
###end article-title 127
###begin article-title 128
Interleukin 1B and interleukin 1RN polymorphisms are associated with increased risk of gastric carcinoma
###end article-title 128
###begin article-title 129
Haploview: analysis and visualization of LD and haplotype maps
###end article-title 129
###begin article-title 130
Perspective on the future use of genomics in exercise prescription
###end article-title 130
###begin article-title 131
###xml 4 9 <span type="species:ncbi:9606">human</span>
The human gene map for performance and health-related fitness phenotypes: the 2006-2007 update
###end article-title 131
###begin article-title 132
###xml 4 9 <span type="species:ncbi:9606">human</span>
The human gene map for performance and health-related fitness phenotypes: the 2005 update
###end article-title 132
###begin article-title 133
###xml 10 15 <span type="species:ncbi:9606">human</span>
Genes and human elite athletic performance
###end article-title 133
###begin article-title 134
Association of interleukin-15 protein and interleukin-15 receptor genetic variation with resistance exercise training responses
###end article-title 134
###begin article-title 135
Long term exercise training decreases IL-6 serum levels in subjects with impaired glucose tolerance: effect of the -174G/C variant in interleukin-6 gene
###end article-title 135
###begin article-title 136
Interleukin-6 genotype is associated with high-density lipoprotein cholesterol responses to exercise training
###end article-title 136
###begin article-title 137
###xml 113 118 <span type="species:ncbi:9606">women</span>
IL-6 gene variation is not associated with increased serum levels of IL-6, muscle, weakness, or frailty in older women
###end article-title 137
###begin article-title 138
###xml 24 29 <span type="species:ncbi:9606">human</span>
Anakinra, a recombinant human interleukin-1 receptor antagonist, inhibits apoptosis in experimental acute myocardial infarction
###end article-title 138
###begin article-title 139
###xml 103 106 <span type="species:ncbi:10116">rat</span>
Effects of physical training on IL-1beta, IL-6 and IL-1ra concentrations in various brain areas of the rat
###end article-title 139
###begin article-title 140
Role of brain IL-1beta on fatigue after exercise-induced muscle damage
###end article-title 140
###begin article-title 141
###xml 63 68 <span type="species:ncbi:9606">human</span>
Regulated expression and release of the IL-1 decoy receptor in human mononuclear phagocytes
###end article-title 141
###begin article-title 142
Interleukin-1-receptor antagonist in type 2 diabetes mellitus
###end article-title 142
###begin article-title 143
Changes in markers of muscle damage, inflammation and HSP70 after an ironman triathlon race
###end article-title 143
###begin article-title 144
Imbalance of the interleukin 1 system in colonic mucosa-association with intestinal inflammation and interleukin 1 receptor antagonist [corrected] genotype 2
###end article-title 144
###begin article-title 145
Functional and ethnic association of allele 2 of the interleukin-1 receptor antagonist gene in ulcerative colitis
###end article-title 145
###begin article-title 146
Interleukin-1 receptor antagonist gene polymorphism and multiple sclerosis
###end article-title 146
###begin article-title 147
Osteoporotic fractures are associated with an 86-base pair repeat polymorphism in the interleukin-1-receptor antagonist gene but not with polymorphisms in the interleukin-1beta gene
###end article-title 147
###begin article-title 148
Interleukin-1B polymorphisms and gastric cancer risk-a meta-analysis
###end article-title 148

